摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(2-aminophenyl)(pyridin-3-yl)methanone | 3882-48-2

中文名称
——
中文别名
——
英文名称
(2-aminophenyl)(pyridin-3-yl)methanone
英文别名
2-aminophenyl-(3-pyridinyl)methanone;(2-Aminophenyl)(3-pyridinyl)methanone;(2-aminophenyl)-pyridin-3-ylmethanone
(2-aminophenyl)(pyridin-3-yl)methanone化学式
CAS
3882-48-2
化学式
C12H10N2O
mdl
——
分子量
198.224
InChiKey
KNZLZNHWLVEHCZ-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    247-249 °C
  • 沸点:
    413.1±25.0 °C(Predicted)
  • 密度:
    1?+-.0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    1.8
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    56
  • 氢给体数:
    1
  • 氢受体数:
    3

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    (2-aminophenyl)(pyridin-3-yl)methanone硫酸 、 sodium nitrite 、 尿素 作用下, 以 为溶剂, 反应 1.25h, 以40%的产率得到4-氮杂-9-芴酮
    参考文献:
    名称:
    An investigation on the second-order NLO properties of novel cationic cyclometallated Ir(III) complexes of the type [Ir(2-phenylpyridine)2(9-R-4,5-diazafluorene)]+ (R=H, fulleridene) and the related neutral complex with the new 9-fulleriden-4-monoazafluorene ligand
    摘要:
    Novel cationic cyclometallated Ir(III) complexes bearing diaza-or monoazafluorene substituted or not with a C60-fullerene moiety have been synthesized together with a novel interesting ligand 9-fulleriden-4-monoazafluorene and the related Ir(III) neutral complex [Ir(ppy)(2)(9-fulleriden-4-monoazafluorene)]. All complexes show a negative large value of mu beta(1.907) (600 to 2190 x 10(-48) esu), as determined by the Electric Field Induced Second Harmonic generation (EFISH) technique working at 1.907 mu m in 10(-3)M CH2Cl2 solution. The NLO response increases upon introduction of the fullerene moiety, due to a decrease of the interaction forces between the anion and cation within the ion pair which leads to an increase of the percentage of free ions, as evidenced by diffusion NMR experiments. Besides, it appeared that for the neutral complex [Ir(ppy)(2)(9-fulleriden-4-monoazafluorene)] the EFISH mu beta(1.907) value is lower than that of cationic Ir(III) complexes, but comparable or slightly lower to the values of other neutral Ir(III) complexes such as [Ir(ppy)(2)(RCOCR'COR)] (ppy = cyclometallated 2-phenylpyridine; R = Me, Ph; R' = H, 2,4-dinitrophenyl), confirming that the second-order NLO response of these neutral chromophores is dominated by ILCT processes concerning cyclometallated 2-phenylpyridines. (C) 2011 Elsevier B. V. All rights reserved.
    DOI:
    10.1016/j.ica.2011.10.018
  • 作为产物:
    描述:
    参考文献:
    名称:
    Street, Jonathan D.; Baradarani, M. Mehdi; Beddoes, Roy L., Journal of Chemical Research, Miniprint, 1987, # 5, p. 1247 - 1285
    摘要:
    DOI:
点击查看最新优质反应信息

文献信息

  • 2-Aminobenzophenones as a Novel Class of Bradykinin B<sub>1</sub>Receptor Antagonists
    作者:Dai-Shi Su、John L. Lim、Elizabeth Tinney、Bang-Lin Wan、Kathy L. Murphy、Duane R. Reiss、C. Meacham Harrell、Stacy S. O’Malley、Rick W. Ransom、Raymond S. L. Chang、Douglas J. Pettibone、Jian Yu、Cuyue Tang、Thomayant Prueksaritanont、Roger M. Freidinger、Mark G. Bock、Neville J. Anthony
    DOI:10.1021/jm800199h
    日期:2008.7
    Selective bradykinin (BK) B 1 receptor antagonists could be novel therapeutic agents for the treatment of pain and inflammation. Elucidation of the structure activity relationships of the structurally novel HTS lead compound 1 provided potent hBK B 1 receptor antagonists with excellent receptor occupancy in the CNS of hBK B 1 transgenic rats.
    选择性缓激肽(BK)B 1受体拮抗剂可能是治疗疼痛和炎症的新型治疗剂。对结构新颖的HTS前导化合物1的结构活性关系的阐明提供了有效的hBK B 1受体拮抗剂,在hBK B 1转基因大鼠的中枢神经系统中具有出色的受体占有率。
  • Deoxygenative Arylation of Carboxylic Acids by Aryl Migration
    作者:Rehanguli Ruzi、Junyang Ma、Xiang‐Ai Yuan、Wenliang Wang、Shanshan Wang、Muliang Zhang、Jie Dai、Jin Xie、Chengjian Zhu
    DOI:10.1002/chem.201903816
    日期:2019.10
    phosphoranyl radical chemistry allows for precise cleavage of a stronger C-O bond and formation of a weaker C-C bond by 1,5-aryl migration under mild reaction conditions. This new protocol is independent of substrate redox-potential, electronic, and substituent effects. It affords a general and promising access to 60 examples of synthetically versatile o-amino and o-hydroxy diaryl ketones under redox-neutral
    已经实现了前所未有的芳香族羧酸脱氧芳基化反应,从而可以构建增强的不对称二芳基酮库。协同的光氧化还原催化作用和烷基自由基化学反应可在温和的反应条件下,通过1,5-芳基迁移,精确裂解更强的CO键并形成较弱的CC键。此新协议独立于底物氧化还原电势,电子和取代基效应。在氧化还原中性条件下,它提供了60种合成通用的邻基和邻羟基二芳基酮的通用且有希望的途径。此外,以令人满意的产率,它也为全合成喹诺酮生物碱,(±)-yaequinolone A2和viridicatin衍生物提供了一条简洁的途径。
  • Development of 1,4-benzodiazepine cholecystokinin type B antagonists
    作者:Mark G. Bock、Robert M. DiPardo、Ben E. Evans、Kenneth E. Rittle、Willie L. Whitter、Victor M. Garsky、Kevin F. Gilbert、James L. Leighton、Kenneth L. Carson
    DOI:10.1021/jm00078a018
    日期:1993.12
    4-benzodiazepines, nonpeptidal antagonists of the peptide hormone cholecystokinin (CCK), are described. Derived by reasoned modification of the CCK-A selective 3-carboxamido-1,4-benzodiazepine, MK-329, this paper chronicles the development of potent, orally effective compounds in which selectivity for the CCK-B receptor subtype was achieved. The principal lead structure that emerged from these studied is
    描述了一系列3-(芳基基)-5-苯基-1,4-苯并二氮杂卓,肽激素胆囊收缩素(CCK)的非肽拮抗剂。通过对CCK-A选择性3-甲酰胺基-1,4-苯并二氮杂卓MK-329的合理修饰而衍生,本文记载了有效的,口服有效的化合物的开发,其中对CCK-B受体亚型具有选择性。从这些研究中得出的主要结构是L-365,260,该化合物已提交临床评估。讨论了通过适当的结构修饰来调节这些苯并二氮杂the的受体相互作用的能力的细节,这暗示了进一步完善这类化合物的CCK-B受体亲和力和选择性的可能性。
  • 一种由芳香羧酸合成邻氨基芳香酮的方法
    申请人:南京大学
    公开号:CN109824530B
    公开(公告)日:2021-09-28
    一种由芳香羧酸制备邻芳香酮的方法,它是以2‑芳基磺酰胺基芳香羧酸为原料,三苯基膦作为脱氧剂,在蓝光灯照射下,在1,4‑二氧六环溶液中,气气氛下,在磷酸氢二存在下,以[Ir(dF(CF3)ppy)2(dtbbpy)]PF6为光催化剂,得到邻芳香酮化合物;所述的光催化剂[Ir(dF( )ppy)2(dtbbpy)]PF6如下结构:。
  • Process and intermediates for the preparation of aryl substituted
    申请人:A. H. Robins Company, Incorporated
    公开号:US04560510A1
    公开(公告)日:1985-12-24
    A process for preparing pyrido[1,4]benzodiazepines having antidepressant activity illustrated by the formula: ##STR1## wherein Ar is pyridinyl, thienyl or phenyl; R is alkali-metal ion, hydrogen, loweralkyl or an amine or an amine precursor on the end of a hydrocarbon chain and wherein in the process condensation of an amino-chloropyridine with an aryl(aminophenyl)methanone is accomplished with a strong non-nucleophilic base in stirrable admixture with an inert liquid carrier. Alternatively, condensation is accomplished sequentially using titanium tetrachloride first followed by non-nucleophilic base.
    一种制备具有抗抑郁活性的吡啶并[1,4]苯二氮杂环己烯的方法,其示例如下:##STR1##其中Ar为吡啶基、噻吩基或苯基;R为碱属离子、氢、较低的烷基或碳氢链末端的胺或胺前体,其中在该过程中,通过在可搅拌的惰性液体载体中与强非亲核碱一起使氯吡啶与芳基(基苯基)甲酮发生缩合来实现。或者,可以先使用四氯化钛,然后使用非亲核碱顺序完成缩合。
查看更多